NCT06298188View on ClinicalTrials.gov

Risankizumab in Children With Crohn's Disease (RisaKids)

NARecruitingINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions

Crohn Disease

Interventions

DRUG

Risankizumab

Risankizumab

Trial Locations (1)

Unknown

RECRUITING

Shaare Zedek Medical Center, Jerusalem

All Listed Sponsors

lead

Shaare Zedek Medical Center

OTHER